Pomerantz LLP investigates Organogenesis Holdings Inc. over alleged securities fraud.

jueves, 22 de enero de 2026, 10:06 am ET1 min de lectura
ORGO--

Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. regarding potential securities fraud or unlawful business practices. The investigation follows the Centers for Medicare & Medicaid Services' withdrawal of final Local Coverage Determinations related to skin substitute grafts/cellular and tissue-based products, which analysts say will increase competition for Organogenesis. As a result, the company's stock price fell 10.14%.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios